Stevanato Group S.p.A.

Equities

STVN

IT0005452658

Medical Equipment, Supplies & Distribution

Market Closed - Nyse 16:00:02 2024-06-14 EDT 5-day change 1st Jan Change
17.77 USD -2.90% Intraday chart for Stevanato Group S.p.A. -4.56% -34.88%
LockThis article is reserved for members
To unlock the article, REGISTER!
Already a customer? Log In
Stevanato Group Inaugurates New Pharma Factory Near Rome MT
Stevanato Group Unveils New Plant in Cisterna Di Latina for the Production of Pre-Sterilized Ez-Fill® Syringes and Cartridges CI
Stevanato Appoints Franco Stevanato as Chief Executive Officer MT
Stevanato Group S.P.A. Announces Chief Executive Officer Changes CI
Stevanato Group S.p.A. Approves Dividend for the Year Ended December 31, 2023 CI
Stevanato Group S.p.A. Approves Board Appointments CI
Certain Common Stock of Stevanato Group S.p.A. are subject to a Lock-Up Agreement Ending on 21-MAY-2024. CI
Transcript : Stevanato Group S.p.A. Presents at Bank of America Health Care Conference 2024, May-15-2024 11:20 AM
Morgan Stanley Lowers Price Target on Stevanato Group to $26 From $30, Keeps Equalweight Rating MT
UBS Adjusts Stevanato Price Target to $24 From $34, Maintains Neutral Rating MT
Sector Update: Health Care Stocks Higher Late Afternoon MT
Sector Update: Health Care Stocks Gain in Thursday Afternoon Trading MT
Stevanato's Q1 Adjusted Earnings, Revenue Fall; 2024 Guidance Cut; Shares Fall 22% MT
Sector Update: Health Care Stocks Steady Pre-Bell Thursday MT
Sector Update: Health Care MT
Transcript : Stevanato Group S.p.A., Q1 2024 Earnings Call, May 09, 2024
Stevanato's Q1 Adjusted Earnings, Revenue Fall; 2024 Guidance Cut MT
Stevanato Group S.p.A. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Stevanato Group S.P.A. Provides Revenue Guidance for 2024 CI
BNP Paribas Exane Initiates Stevanato Group With Outperform Rating MT
Stevanato Group Names Ugo Gay as Chief Operations Officer MT
Stevanato Group S.p.A. Announces the Appointment of Ugo Gay as Chief Operations Officer CI
Stevanato Group Closes $379.7 Million Public Share Offering MT
Stevanato Group Prices Upsized $330 Million Public Share Offering; Shares Rise MT
Sector Update: Health Care Stocks Steady Pre-Bell Friday MT
Chart Stevanato Group S.p.A.
More charts
Stevanato Group SpA is an Italy-based manufacturer and distributor engaged in two segments: Biopharmaceutical and Diagnostic Solutions and Engineering, including the production and distribution of drug containment solutions, drug delivery systems, and diagnostic solutions in the pharmaceutical industry. The Company delivers products, processes, and services across all stages of drug developments, including pre-clinical, clinical, and commercialization. Its Engineering segment includes the equipment and technologies developed and provided to support the end-to-end pharmaceutical, biotechnology, and diagnostic manufacturing processes. The Company operates locally, in Europe, and globally, including Brazil, China, Mexico, and the United States.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
17.77 USD
Average target price
28.66 USD
Spread / Average Target
+61.30%
Consensus
  1. Stock Market
  2. Equities
  3. STVN Stock
  4. News Stevanato Group S.p.A.
  5. Sector Update: Health Care Stocks Steady Pre-Bell Thursday